RECOMBIVAX HB is a Intramuscular; Subcutaneous Injection, Suspension in the Vaccine category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Hepatitis B Virus Subtype Adw Hbsag Surface Protein Antigen.
| Product ID | 0006-4995_154095f6-aada-4a3f-a0b2-76009c1922e4 |
| NDC | 0006-4995 |
| Product Type | Vaccine |
| Proprietary Name | RECOMBIVAX HB |
| Generic Name | Hepatitis B Vaccine (recombinant) |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAMUSCULAR; SUBCUTANEOUS |
| Marketing Start Date | 1986-07-23 |
| Marketing Category | BLA / BLA |
| Application Number | BLA101066 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN |
| Active Ingredient Strength | 10 ug/mL |
| Pharm Classes | Inactivated Hepatitis B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis B Vaccines [CS],Vaccines, Inactivated [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 1986-07-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA101066 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 1986-07-23 |
| Marketing Category | BLA |
| Application Number | BLA101066 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2013-09-06 |
| Marketing Category | BLA |
| Application Number | BLA101066 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 1986-07-23 |
| Ingredient | Strength |
|---|---|
| HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN | 10 ug/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-4093 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 0006-4094 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 0006-4981 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 0006-4992 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 0006-4995 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 50090-1716 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 50090-1719 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 50090-1849 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 50090-1223 | ENGERIX-B | Hepatitis B Vaccine (Recombinant) |
| 50090-1706 | ENGERIX-B | Hepatitis B Vaccine (Recombinant) |
| 58160-820 | ENGERIX-B | Hepatitis B Vaccine (Recombinant) |
| 58160-821 | ENGERIX-B | Hepatitis B Vaccine (Recombinant) |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RECOMBIVAX HB 73509689 1338762 Live/Registered |
Merck & Co., Inc. 1984-11-19 |